Multiple Spider Angiomas in a Patient with Chronic Hepatic Graft-Versus-host Disease

Ying Gu,Kun Li,Xia Wu,Jian-Zhong Zhang
DOI: https://doi.org/10.1097/cm9.0000000000000707
IF: 6.133
2020-01-01
Chinese Medical Journal
Abstract:A 40-year-old man with acute myeloid leukemia received hematopoietic stem-cell transplantation (HSCT) 7 years ago. Five months after HSCT, he developed chronic hepatic GVHD. Hepatic GVHD was diagnosed by a hematologist according to abnormal liver function tests (LFTs), elevations in bilirubin. In recent 2 years, he noticed multiple red spots on the neck [Figure 1A], arms [Figure 1B and 1C], and upper trunk [Figure 1D]. Physical examination revealed multiple telangiectatic macules, characterized by central arteriole with radiated blood vessels. Compression of central area caused the entire telangiectasia to blanch. He also had tender gynecomastia. Laboratory findings included increase in total bilirubin 29.8 mmol/L (normal value <21mmol/L), direct bilirubin 15.1 mmol/L (normal value <7mmol/L), total bile acid 56.1 mmol/L (normal value <10mmol/L), alanine transaminase 48 IU/L (normal value <40 IU/L), aspartate transaminase 65 IU/L (normal value <40 IU/L), alkaline phosphatase 169 IU/L (normal value <125 IU/L), gamma glutamyl transpeptidas 109 IU/L (normal value <60 IU/L), and decrease in serum albumin 29 g/L (normal value >40 g/L). Hepatitis B surface antigen (HBsAg) and hepatitis C virus (HCV) antibodies were both negative. Abdominal ultrasound revealed a nodular liver surface. Esophageal varices were not found. The patient denied the history of alcoholic hepatitis or viral hepatitis. He had no history of using suspected drugs which affected estrogen metabolism. He was diagnosed as spider angiomas associated to hepatic GVHD andwas treated with systemic steroids. The abnormality of liver function was successfully controlled while the telangiectasia remained unchanged.
What problem does this paper attempt to address?